Adult attention deficit hyperactivity disorder: translating research into practice (Q37986704)

26 August 2017

Adult attention deficit hyperactivity disorder: translating research into practice (English)

1 reference

adult attention deficit hyperactivity disorder

26 August 2017

0 references

1 reference

3

1 reference

26 August 2017

A N Coogan

1

1 reference

26 August 2017

A Dobrean

2

1 reference

26 August 2017

L Mateescu

4

1 reference

26 August 2017

U Müller

5

1 reference

26 August 2017

J Thome

6

1 reference

26 August 2017

B I Voinescu

7

1 reference

26 August 2017

16 February 2012

1 reference

ADHD - Attention Deficit and Hyperactivity Disorders

26 August 2017

1 reference

26 August 2017

4

1 reference

26 August 2017

1

1 reference

26 August 2017

41-51

1 reference

https://scigraph.springernature.com/pub.10.1007/s12402-012-0073-7

26 August 2017

0 references

cites work

Long-term, open-label safety and efficacy of atomoxetine in adults with ADHD: final report of a 4-year study.

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Is ADHD a valid diagnosis in adults? Yes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Immune proteins in brain development and synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Inflammation: good or bad for ADHD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Cognitive behaviour therapy in medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Impulsive choice in a rodent model of attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Strengths and limitations of genetic models of ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Role for the membrane receptor guanylyl cyclase-C in attention deficiency and hyperactive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

A polymorphism at the 3'-untranslated region of the CLOCK gene is associated with adult attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Efficacy of ADHD coaching for adults with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Molecular genetic contribution to the developmental course of attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Responding to requests from adult patients for neuroenhancements: guidance of the Ethics, Law and Humanities Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Considerations about the efficacy of psychopharmacological drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Sequence analysis of Drd2, Drd4, and Dat1 in SHR and WKY rat strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Psychosocial treatments for ADHD in teens and adults: a practice-friendly review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Possible confusion between primary hypersomnia and adult attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Evaluation of the efficacy and effectiveness of a structured disorder tailored psychotherapy in ADHD in adults: study protocol of a randomized controlled multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Brain gray matter deficits at 33-year follow-up in adults with attention-deficit/hyperactivity disorder established in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Psychometric and psychopathological characterization of young male prison inmates with and without attention deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

A functional serotonin transporter promoter gene polymorphism increases ADHD symptoms in delinquents: interaction with adverse childhood environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Pharmacological treatment of adult ADHD in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Are patient-administered attention deficit hyperactivity disorder scales suitable for adults?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Itches and scratches – is there a link between eczema, ADHD, sleep disruption and food hypersensitivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Psychopathological rating scales as efficacy parameters in adult ADHD treatment investigations - benchmarking instruments for international multicentre trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

A combined treatment approach for adults with ADHD--results of an open study of 43 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Impulsiveness, overactivity, and poorer sustained attention improve by chronic treatment with low doses of l-amphetamine in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Rodent models of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Anatomical and functional brain imaging in adult attention-deficit/hyperactivity disorder (ADHD)--a neurological view

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Sleep quality in adult patients with attention deficit hyperactivity disorder (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Transgenic mice expressing a human mutant beta1 thyroid receptor are hyperactive, impulsive, and inattentive.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

The effect of chronic methylphenidate administration on presynaptic dopaminergic parameters in a rat model for ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Advances in genetic studies of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Development of a new psychosocial treatment for adult ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Animal models of attention deficit/hyperactivity disorder (ADHD): a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Antecedents of ADHD: a historical account of diagnostic concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Scales for the identification of adults with attention deficit hyperactivity disorder (ADHD): a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Attention deficit hyperactivity disorder (ADHD) in a 19th century children's book.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Idiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: a circadian rhythm sleep disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Delayed circadian rhythm in adults with attention-deficit/hyperactivity disorder and chronic sleep-onset insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Reliability and validity of self- and other-ratings of symptoms of ADHD in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

21 January 2018

Complement in the brain.

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Adults with ADHD benefit from cognitive-behaviorally oriented group rehabilitation: a study of 29 participants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Evaluating dopamine reward pathway in ADHD: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Association study between a polymorphism at the 3'-untranslated region of CLOCK gene and attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

Neuroimaging as endpoints in clinical trials: Are we there yet? Perspective from the first Provence workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12402-012-0073-7

10.1007/S12402-012-0073-7

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference